ZEISS Group is a German technology enterprise in optics and optoelectronics, founded in 1846 and operating across 50 countries with approximately 46,600 employees. The company generates nearly €12 billion in annual revenue and invests 15% of that directly into research and development. ZEISS is wholly owned by the Carl Zeiss Foundation, a structure that underpins its long-term research commitments and approach to technology development.
The company's technical portfolio spans semiconductor manufacturing technology, research microscopy, industrial quality solutions, medical technology, and consumer optics. In semiconductor manufacturing, ZEISS provides enabling technology for microchip production. Its research microscopy systems allow visualization of structures at the smallest scales, while industrial quality solutions address measurement and inspection challenges in manufacturing environments. The medical technology division covers ophthalmology, microsurgery, and vision care applications. ZEISS has also begun work in extended reality as an emerging field.
ZEISS operates across multiple technical domains including optics, optoelectronics, quality assurance systems, and medical devices. The company's work intersects with robotics-relevant areas in precision measurement, industrial automation, microscopy imaging systems, and manufacturing process control. Current company initiatives address sustainability, digitalization, and energy-related technologies, with a stated target of carbon neutrality by 2024/25. The foundation ownership model enables funding of scientific research programs in areas ranging from aging societies to circular economy applications.
